Details of the Drug
General Information of Drug (ID: DM6F0C4)
| Drug Name |
2-Benzylsulfanyl-6-chloro-pyrimidin-4-ylamine
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
4-Amino-2-(benzylthio)-6-chloropyrimidine; 99983-92-3; CHEMBL124578; U-31,355; 2-benzylmercapto-4-amino-6-chloropyrimidine; 2-(benzylthio)-6-chloropyrimidin-4-amine; 2-Benzylsulfanyl-6-chloro-pyrimidin-4-ylamine; AC1Q3RY2; AC1L3VC9; U 31355; SCHEMBL489860; 4-Pyrimidinamine, 6-chloro-2-((phenylmethyl)thio)-; U 31,355; CTK5I0853; ZINC21246; DTXSID20244368; LGTXUPUULSWTNA-UHFFFAOYSA-N; BDBM50066933; AKOS030548304; KB-239927; 2-benzylsulfanyl-6-chloropyrimidin-4-amine; 2-benzylsulfanyl-6-chloro-pyrimidin-4-amine
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 251.74 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3.2 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


